AACR Announces Official Call for Papers for New Open Access Journal, Cancer Research Communications
PHILADELPHIA — The American Association for Cancer Research (AACR) today announced the opening of the submission site for its...
PHILADELPHIA — The American Association for Cancer Research (AACR) today announced the opening of the submission site for its...
Patients with cancer may not receive full benefit of vaccination and are at higher risk for severe illness and...
PHILADELPHIA – Today, the American Association for Cancer Research (AACR) announced the creation of two career development awards (CDAs)...
Fifty years after the signing of the National Cancer Act, rapid progress against cancer for patients continues Medical research...
PHILADELPHIA — The American Association for Cancer Research (AACR) today expressed its gratitude to Francis S. Collins, MD, PhD,...
PHILADELPHIA – Combination of the KRAS inhibitor sotorasib (Lumakras) with afatinib, a pan-ErbB tyrosine kinaseinhibitor, was feasible in treating...
PHILADELPHIA – In a phase II clinical trial, the drug 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) improved survival for some adolescent and young...
PHILADELPHIA – A peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint...
PHILADELPHIA – In preclinical models, combining an investigational Aurora Kinase A (AURKA) inhibitor with a KRAS inhibitor or a...
PHILADELPHIA – Black/African American patients with prostate cancer who were treated with the androgen receptor inhibitor darolutamide (Nubeqa) had...